Suchergebnisse - "Cervantes, A"

PubPharm (442)

61

Managing cancer patients during the COVID-19 pandemic : an ESMO multidisciplinary expert consensus

enthalten in: Annals of oncology | 31 July 2020

von Curigliano, G. | Banerjee, S. | Cervantes, A. | +12

62

Targeted next-generation sequencing of circulating-tumor DNA for tracking minimal residual disease in localized colon cancer

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2019

von Tarazona, N. | Gimeno-Valiente, F. | Gambardella, V. | +17

63

Hereditary gastrointestinal cancers : ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2019

von Stjepanovic, N. | Moreira, L. | Carneiro, F. | +5

CommentIn: Ann Oncol. 2019 Oct 1;30(10):1535-1536. - PMID 31504125

64

Growth Mechanism and Properties of Self-Assembled InN Nanocolumns on Al Covered Si(111) Substrates by PA-MBE

enthalten in: Materials (Basel, Switzerland) | 2019

von Casallas-Moreno, Y. | Gallardo-Hernández, S. | Yee-Rendón, C. | +7

65

Understanding the clinical behavior of relapsed colon cancers with microsatellite instability relative to BRAF mutations

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2019

von Roda, D. | Roselló, S. | Cervantes, A.

CommentOn: Ann Oncol. 2019 Sep 1;30(9):1466-1471. - PMID 31268130

66

Towards precision oncology for HER2 blockade in gastroesophageal adenocarcinoma

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2019

von Gambardella, V. | Fleitas, T. | Tarazona, N. | +8

67

Atezolizumab with or without cobimetinib versus regorafenib in previously treated metastatic colorectal cancer (IMblaze370) : a multicentre, open-label, phase 3, randomised, controlled trial

enthalten in: The Lancet. Oncology | 2019

von Eng, C. | Kim, T. | Bendell, J. | +77

CommentIn: Lancet Oncol. 2019 Jun;20(6):752-753. - PMID 31003912

68

Symposium review : Technologies for improving fiber utilization

enthalten in: Journal of dairy science | 2019

von Adesogan, A. | Arriola, K. | Jiang, Y. | +6

69

Author Correction : Combination of KIR2DS4 and FcγRIIa polymorphisms predicts the response to cetuximab in KRAS mutant metastatic colorectal cancer

enthalten in: Scientific reports | 2019

von Borrero-Palacios, A. | Cebrián, A. | Gómez Del Pulgar, M. | +21

ErratumFor: Sci Rep. 2019 Feb 22;9(1):2589. - PMID 30796344

70

Correction to : “Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up"

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2019

von Vogel, A. | Cervantes, A. | Chau, I. | +12

ErratumFor: Ann Oncol. 2018 Oct 1;29(Suppl 4):iv238-iv255. - PMID 30285213